Evaluation of dental implants as a risk factor for the development of bisphosphonate-related osteonecrosis of the jaw in breast cancer patients

American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update

Salvatore L. Ruggiero, Thomas B. Dodson, John E Fantasia et al. · Journal of Oral and Maxillofacial Surgery · 2014 · 2.9K citations

Dentistry, Maxillofacial Surgery, Oral Surgery +3

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

Elizabeth Shane, David B. Burr, Peter R. Ebeling et al. · Journal of Bone and Mineral Research · 2010 · 1.1K citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +15

Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates

Ana O. Hoff, Béla B. Toth, Kadri Altundağ et al. · Journal of Bone and Mineral Research · 2008 · 634 citations · Full text

Medicine, Oncology, Oral Surgery +13

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

James R. Berenson, Lee S. Rosen, Anthony Howell et al. · Cancer · 2001 · 532 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid

Meletios Α. Dimopoulos, Efstathios Kastritis, Christina Bamia et al. · Annals of Oncology · 2008 · 437 citations · Full text

Medicine, Oncology, Bone Metabolism +9